Trial Details

RECRUITING
Basic Information
Clinical ID c132
Identifier NCT06382519
Trial Title Thalidomide Therapy for VEOIBD
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Inflammatory Bowel Diseases
Interventions DRUG: Thalidomide
Participant Information
Sponsor Children's Hospital of Fudan University
City Shanghai
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2024-05-15
Primary Completion Date 2025-12-31
Completion Date 2026-12-31